Literature DB >> 6411067

Platelet-activating factor stimulates phosphatidylinositol turnover in human platelets.

D E MacIntyre, W K Pollock.   

Abstract

Platelet-activating factor stimulates phosphatidylinositol turnover in human platelets as indicated by [32P]phosphatidate accumulation in platelets pre-labelled with [32P]Pi, and by [3H]phosphatidate accumulation and [3H]phosphatidylinositol loss in platelets pre-labelled with [3H]arachidonate. These effects of platelet-activating factor are direct and are independent of the production and/or release of endogenous platelet agonists such as ADP, 5-hydroxytryptamine and thromboxane A2.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6411067      PMCID： PMC1152064          DOI： 10.1042/bj2120433

Source DB:  PubMed          Journal:  Biochem J        ISSN： 0264-6021            Impact factor:   3.857


  21 in total

Review 1.  Inositol phospholipids and cell surface receptor function.

Authors:  R H Michell
Journal:  Biochim Biophys Acta       Date:  1975-03-25

2.  Separation and analysis of 32P-labeled phospholipids by a simple and rapid thin-layer chromatographic procedure and its application to cultured neuroblastoma cells.

Authors:  E Yavin; A Zutra
Journal:  Anal Biochem       Date:  1977-06       Impact factor: 3.365

3.  Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP.

Authors:  R J Haslam; M M Davidson; J V Desjardins
Journal:  Biochem J       Date:  1978-10-15       Impact factor: 3.857

4.  Prostaglandin receptors on human platelets. Structure-activity relationships of stimulatory prostaglandins.

Authors:  D E MacIntyre; E W Salzman; J L Gordon
Journal:  Biochem J       Date:  1978-09-15       Impact factor: 3.857

5.  Effect of ADP-induced shape change on incorporation of 32P into platelet phosphatidic acid and mono-, di- and triphosphatidyl inositol.

Authors:  J V Lloyd; E E Nishizawa; J F Mustard
Journal:  Br J Haematol       Date:  1973-07       Impact factor: 6.998

6.  Changes in 32 p-labelling of platelet phospholipids in response to ADP.

Authors:  J V Lloyd; E E Nishizawa; J Haldar; J F Mustard
Journal:  Br J Haematol       Date:  1972-11       Impact factor: 6.998

7.  Phospholipids as ionophores.

Authors:  C A Tyson; H Vande Zande; D E Green
Journal:  J Biol Chem       Date:  1976-03-10       Impact factor: 5.157

8.  Production of diglyceride from phosphatidylinositol in activated human platelets.

Authors:  S Rittenhouse-Simmons
Journal:  J Clin Invest       Date:  1979-04       Impact factor: 14.808

9.  Stimulation of phosphatidic acid production in platelets precedes the formation of arachidonate and parallels the release of serotonin.

Authors:  E G Lapetina; P Cuatrecasas
Journal:  Biochim Biophys Acta       Date:  1979-05-25

10.  Leukocyte-dependent histamine release from rabbit platelets. The role of IgE, basophils, and a platelet-activating factor.

Authors:  J Benveniste; P M Henson; C G Cochrane
Journal:  J Exp Med       Date:  1972-12-01       Impact factor: 14.307
View more
  19 in total

Review 1.  Bioactions of 5-hydroxyicosatetraenoate and its interaction with platelet-activating factor.

Authors:  A G Rossi; J T O'Flaherty
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

2.  Thrombin, unlike vasopressin, appears to stimulate two distinct guanine nucleotide regulatory proteins in human platelets.

Authors:  M D Houslay; D Bojanic; D Gawler; S O'Hagan; A Wilson
Journal:  Biochem J       Date:  1986-08-15       Impact factor: 3.857

3.  [Relation between post-thrombotic syndrome, ADP-induced thrombocyte aggregation and intrathrombocyte calcium content].

Authors:  B Heintz; C Femers; N Maurin; H Kierdorf; C Brilon; V Wienert
Journal:  Klin Wochenschr       Date:  1989-12-04

Review 4.  Inositol phospholipid turnover in PAF transmembrane signalling.

Authors:  S D Shukla
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

5.  Heparin and heparinoids impair adrenaline and platelet-activating factor but not thrombin-induced inhibition of adenylate cyclase and stimulation of GTP hydrolysis in human platelet membranes.

Authors:  B Willuweit; K Aktories
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-03       Impact factor: 3.000

6.  The local anaesthetic benzyl alcohol attenuates the alpha 2-adrenoceptor-mediated inhibition of human platelet adenylate cyclase activity when stimulated by prostaglandin E1, but not that stimulated by forskolin.

Authors:  S Spence; M D Houslay
Journal:  Biochem J       Date:  1989-12-01       Impact factor: 3.857

7.  Stimulus-response coupling in human platelets. Changes evoked by platelet-activating factor in cytoplasmic free calcium monitored with the fluorescent calcium indicator quin2.

Authors:  T J Hallam; A Sanchez; T J Rink
Journal:  Biochem J       Date:  1984-03-15       Impact factor: 3.857

8.  The role of Gi and the membrane-fluidizing agent benzyl alcohol in modulating the hysteretic activation of human platelet adenylate cyclase by guanylyl 5'-imidodiphosphate.

Authors:  S Spence; M D Houslay
Journal:  Biochem J       Date:  1993-05-01       Impact factor: 3.857

9.  Possible mechanisms of the potentiation of blood-platelet activation by adrenaline.

Authors:  M Bushfield; A McNicol; D E MacIntyre
Journal:  Biochem J       Date:  1987-02-01       Impact factor: 3.857

10.  Thromboxane-induced phosphatidate formation in human platelets. Relationship to receptor occupancy and to changes in cytosolic free calcium.

Authors:  W K Pollock; R A Armstrong; L J Brydon; R L Jones; D E MacIntyre
Journal:  Biochem J       Date:  1984-05-01       Impact factor: 3.857
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.